STAAR Surgical Shares Outstanding 2012-2026 | STAA

STAAR Surgical shares outstanding from 2012 to 2026. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
Unlock Macrotrends Premium
40 years of data
Faster, ad-free pages
Unlimited data exports
Full-width charts
STAAR Surgical Annual Shares Outstanding
(Millions of Shares)
2025 50
2024 49
2023 49
2022 49
2021 49
2020 48
2019 47
2018 45
2017 41
2016 40
2015 39
2014 38
2013 39
2012 36
2011 37
STAAR Surgical Quarterly Shares Outstanding
(Millions of Shares)
2026-03-31 51
2025-12-31 50
2025-09-30 51
2025-06-30 50
2025-03-31 49
2024-12-31 49
2024-09-30 50
2024-06-30 50
2024-03-31 49
2023-12-31 49
2023-09-30 49
2023-06-30 50
2023-03-31 50
2022-12-31 49
2022-09-30 50
2022-06-30 49
2022-03-31 49
2021-12-31 49
2021-09-30 50
2021-06-30 49
2021-03-31 49
2020-12-31 48
2020-09-30 48
2020-06-30 45
2020-03-31 45
2019-12-31 47
2019-09-30 47
2019-06-30 47
2019-03-31 47
2018-12-31 45
2018-09-30 46
2018-06-30 44
2018-03-31 43
2017-12-31 41
2017-09-30 42
2017-06-30 41
2017-03-31 41
2016-12-31 40
2016-09-30 40
2016-06-30 40
2016-03-31 40
2015-12-31 39
2015-09-30 40
2015-06-30 39
2015-03-31 38
2014-12-31 38
2014-09-30 38
2014-06-30 38
2014-03-31 38
2013-12-31 39
2013-09-30 39
2013-06-30 38
2013-03-31 37
2012-12-31 36
2012-09-30 36
2012-06-30 36
2012-03-31 38
2011-12-31 37
2011-09-30 37
2011-06-30 36
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $1.309B $0.239B
Staar Surgical Company has evolved to become a developer, manufacturer and global distributor of products used by ophthalmologists and other eye care professionals to improve or correct vision in patients suffering from refractive conditions, cataracts and glaucoma.
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $106.025B 23.03
Cardinal Health (CAH) United States $50.715B 22.43
Becton Dickinson (BDX) United States $43.913B 11.10
West Pharmaceutical Services (WST) United States $18.493B 35.19
Straumann Holding AG (SAUHY) Switzerland $16.902B 0.00
Cooper (COO) United States $13.894B 16.52
Align Technology (ALGN) United States $12.400B 21.09
Henry Schein (HSIC) United States $8.645B 15.16
Merit Medical Systems (MMSI) United States $4.072B 19.84
DENTSPLY SIRONA (XRAY) United States $2.339B 7.36
CONMED (CNMD) United States $1.107B 7.97
Pro-Dex (PDEX) United States $0.165B 19.65
Lifevantage (LFVN) United States $0.053B 5.46
Axe Compute (AGPU) United States $0.022B 0.00